Cat.#: ACPP-1225
| Despition | POMT1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1614 | Human MPPED2 Protein (AC1614) | 2 µg | inquiry |
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1525 | Human PCDHGC4 Protein (AC1525) | 5 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1630 | Human ENO2 Protein, His (AC1630) | 2 µg | inquiry |
| ACPP-1141 | Recombinant Human Prion Protein PrP Protein (Fc Tag) (AC1141) | 50 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.